Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Journal of the European Academy of Dermatology and Venereology : JEADV|June 18, 2026
Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic reviewFatimah Khoda, Yasmin Khan, William W Y Haw, et al.
Arthritis Research & Therapy|July 9, 2016
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathiesJoanna E Parkes, Simon Rothwell, Philip J Day, et al.
Rheumatology (Oxford, England)|March 15, 2018
Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathiesJames B Lilleker, Axel C P Diederichsen, Søren Jacobsen, et al.
RMD Open|January 27, 2017
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RAMeghna Jani, William G Dixon, Lianne Kersley-Fleet, et al.
Lancet (London, England)|August 28, 2015
Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Rheumatology (Oxford, England)|November 30, 2018
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohortMatthew J S Parker, Alexander Oldroyd, Mark E Roberts, et al.
The Journal of Rheumatology|August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis SymptomsLisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Communications Biology|March 27, 2021
Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositisSpyridon Megremis, Thomas D J Walker, Xiaotong He, et al.
Rheumatology (Oxford, England)|November 8, 2024
Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositisFionnuala K McMorrow, Lucy R Wedderburn, Hector Chinoy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Pageof 18